Which brands do Americans trust the most? Kleenex, Ghirardelli, Vaseline among favorites
Kleenex and Ghirardelli Chocolate are among the 500 brands that Americans trust the most, according to new research from USA ...
BioSpace22h
GSK Wins FDA Nod for First Oral UTI Antibiotic in Almost 30 Years
Blujepa, which treats UTIs in female patients aged 12 and up with common and uncomplicated infections, will hit the market in ...
EMA to review GSK’s Nucala for COPD treatment expansion
GSK’s application is underpinned by the positive outcomes from the Phase III MATINEE trial, which demonstrated a significant ...
exchange4media5d
Puneet Das wins The CMO Leadership Award at the Pitch CMO Summit 2025
At Tata Consumer Products, Das drives growth strategy, outcomes and profit & loss for the packaged beverages category in ...
2 FTSE 100 stocks that investors should consider for income
Our writer Ken Hall evaluates two defensive dividend payers in the FTSE 100 that he thinks investors should consider buying ...
Investing Snacks6d
Bye-Bye, Band-Aids: Pfizer Wraps Up Haleon Exit
Pfizer has officially kissed goodbye to its consumer health venture by selling its final 7.3% stake in Haleon for a tidy $3.3 ...
Pfizer Sells Remaining 7.3% Stake in Haleon for Around 3.3B
Pfizer PFE has sold off its remaining stake in consumer health company Haleon HLN to institutional investors and Haleon ...
Pharmaceutical Technology on MSN6d
Pfizer sells 7.3% stake in Haleon for $3.3bn
The disposal represents Pfizer's exit from its investment in Haleon, which originated from a JV formed with GSK in 2019.
Fierce Pharma7d
Pfizer pockets roughly £2.5B as it shaves off final stake in consumer health spinoff Haleon
With Pfizer’s final stake sale in the bag, the two Big Pharma companies behind Haleon’s genesis have formally parted ways with the standalone consumer health giant. | After charting similar moves ...
Medical Dialogues7d
Pfizer to exit Haleon
Bengaluru: Pfizer will divest its remaining stake in Haleon, marking its complete exit from the British consumer healthcare ...
City snapshot: Pfizer completes £2.5bn Haleon exit
Pfizer still owns about 7.3% of the company making it the largest shareholder. GSK sold its remaining stake in May last year.
Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion
Pfizer sold its entire 7.3% shareholding in London-listed consumer-health company Haleon for a net sum of 2.5 billion pounds ($3.25 billion). Pfizer sold 618 million shares for 385 pence each. The ...